These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19245436)

  • 61. A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
    Daelemans D; Schols D; Witvrouw M; Pannecouque C; Hatse S; van Dooren S; Hamy F; Klimkait T; de Clercq E; VanDamme AM
    Mol Pharmacol; 2000 Jan; 57(1):116-24. PubMed ID: 10617686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis.
    Nishita M; Aizawa H; Mizuno K
    Mol Cell Biol; 2002 Feb; 22(3):774-83. PubMed ID: 11784854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
    Gros SJ; Graeff H; Drenckhan A; Kurschat N; Blessmann M; Rawnaq T; Izbicki JR
    In Vivo; 2012; 26(4):711-8. PubMed ID: 22773586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The chemokine SDF-1alpha suppresses fibronectin-mediated in vitro lymphocytes adhesion.
    Lili J; Yuchen S; Zhengtao W
    Mol Cells; 2006 Dec; 22(3):308-13. PubMed ID: 17202859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
    Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Lapidot A; Peled A; Berchanski A; Pal B; Kollet O; Lapidot T; Borkow G
    Biochim Biophys Acta; 2008 Jun; 1780(6):914-20. PubMed ID: 18410746
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
    Richardson J; Pancino G; Merat R; Leste-Lasserre T; Moraillon A; Schneider-Mergener J; Alizon M; Sonigo P; Heveker N
    J Virol; 1999 May; 73(5):3661-71. PubMed ID: 10196258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stromal cell-derived factor 1-alpha (SDF)-induced human T cell chemotaxis becomes phosphoinositide 3-kinase (PI3K)-independent: role of PKC-theta.
    Shahabi NA; McAllen K; Sharp BM
    J Leukoc Biol; 2008 Mar; 83(3):663-71. PubMed ID: 18055570
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The proline-rich region of HIV-1 Nef affects CXCR4-mediated chemotaxis in Jurkat T cells.
    Lee CM; Gala S; Stewart GJ; Williamson P
    Viral Immunol; 2008 Sep; 21(3):347-54. PubMed ID: 18707241
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator.
    Lazzarino DA; Diego M; Musi E; Hirschman SZ; Alexander RJ
    Immunol Lett; 2000 Nov; 74(3):189-95. PubMed ID: 11064099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SDF-1/54-DCN: a novel recombinant chimera with dual inhibitory effects on proliferation and chemotaxis of tumor cells.
    Ma W; Cai S; Du J; Tan Y; Chen H; Guo Z; Hu H; Fang R; Cai S
    Biol Pharm Bull; 2008 Jun; 31(6):1086-91. PubMed ID: 18520035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comodulation of CXCR4 and CD26 in human lymphocytes.
    Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
    J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
    Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
    J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.
    Thakkar N; Pirrone V; Passic S; Keogan S; Zhu W; Kholodovych V; Welsh W; Rando R; Labib M; Wigdahl B; Krebs FC
    Antimicrob Agents Chemother; 2010 May; 54(5):1965-72. PubMed ID: 20231400
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1α probed by a novel synthetically and modularly modified-chemokine analog.
    Dong CZ; Tian S; Madani N; Choi WT; Kumar S; Liu D; Sodroski JG; Huang Z; An J
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1413-9. PubMed ID: 22101518
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
    Takamune N; Misumi S; Shoji S
    Biochem Biophys Res Commun; 2000 Jun; 272(2):351-6. PubMed ID: 10833417
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.
    Thakkar N; Pirrone V; Passic S; Zhu W; Kholodovych V; Welsh W; Rando RF; Labib ME; Wigdahl B; Krebs FC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):631-8. PubMed ID: 19047650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.
    Okabe S; Fukuda S; Kim YJ; Niki M; Pelus LM; Ohyashiki K; Pandolfi PP; Broxmeyer HE
    Blood; 2005 Jan; 105(2):474-80. PubMed ID: 15345598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor.
    Esté JA; Cabrera C; De Clercq E; Struyf S; Van Damme J; Bridger G; Skerlj RT; Abrams MJ; Henson G; Gutierrez A; Clotet B; Schols D
    Mol Pharmacol; 1999 Jan; 55(1):67-73. PubMed ID: 9882699
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.